Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Dr. Scott Kahn Joins Optra Health as Chief Strategy Advisor

Optra Health
Posted on: 14 Sep 16

Optra Health today announced that Dr. Scott Kahn will serve as Chief Strategy Advisor overseeing strategic direction for the Company’s Knowledge Automation and Analytics Platform iPhronesis™ for genomics-related research, digital drug development, real world evidence and Personalized Healthcare.

Dr. Kahn most recently served as Vice President for Illumina’s Enterprise Informatics group after serving as Illumina’s Chief Information Officer for nine years. ”The field of Precision Medicine is rapidly being defined as tools to aggregate and sanitize research and clinical information come to the fore, and the iPhronesis platform is making inroads that can be levered on many fronts to advance the field,” comments Dr. Kahn.

“We are investing in our data-driven healthcare platform development combining Machine-learning and natural language processing technologies. Having Dr. Kahn advise on the overall strategic plan for iPhronesis™ will guide our strategic partnerships towards accelerating Precision Medicine efforts across Clinical Genomics, Pharma and Personalized Healthcare,“ said Dr. Gauri Naik, Optra Health’s co-founder and CEO.

Optra Health will be exhibiting at the upcoming Festival of Genomics at booth #411 in San Diego, CA, September 20-21 and demonstrating iPhronesis and its applications. Dr. Kahn will also be a part of the Drug Development track panel on Day 2 “Looking Forward - Opportunities to Disrupt Medicines Development Through Human Genetics.”

About Optra Health and iPhronesis™

Optra Health is a Digital Healthcare company specializing in machine learning-based knowledge automation analytics for the Life Sciences and Healthcare industries. Optra Health’s Analytics platform iPhronesis™ with knowledge automation engine is used for clinical genomics, real world evidence and Personalized and Precision Medicine applications.

iPhronesis™ integrates all aspects of research and diagnostics across databases, both structured and unstructured and provides powerful workflows with the latest analytics and visualization technologies. At the core of iPhronesis is a BioNLP-powered knowledge automation framework for creating meaningful structured corpora that allows for easy querying using natural language. Specifically, iPhronesis supports biomedical data, ranging from genomics and proteomics, drugs, pathways, clinical lab reports and EMR/EHR records.

Specific applications for iPhronesis include genomic apps for creating robust genomics reporting pipelines, variant pathogenicity identification, variant knowledgebases, genotype-phenotype correlations, cancer genomics, drug-gene insights, in-silico drug design, drug repurposing, toxicity & efficacy studies, epigenetic markers, pathological reports/annotations, clinical grade personalized risk reports for prenatal screening and counselling for diagnostic labs.

View source version on

Business Wire

Last updated on: 14/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.